-
Diagnostics World News | Most patients, as well as most primary care physicians, consider lung cancer to be highly lethal. That’s because early-stage disease tends to be discovered by accident rather than intentionally through screening, leading Lahey Hospital & Medical Center to develop a high-volume CT lung cancer screening program, which is scanning about 65% of the eligible population with impressive results.
Dec 9, 2019
-
Diagnostics World News | Sight Diagnostics' AI-based blood diagnostics device—called OLO—recently received 510(k) clearance for the US Food and Drug Administration (FDA), allowing the device to be marketed and sold in the US.
Dec 6, 2019
-
Diagnostics World News | Veracyte announced today that it has executed a definitive agreement with NanoString for the exclusive global license to the nCounter platform for diagnostic use as well as other tests for $40 million in cash and $10 million in stock.
Dec 3, 2019
-
Diagnostics World News | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Proscia, Vela, Certara, and more.
Nov 27, 2019
-
Diagnostics World News | Researchers recently took a step towards unraveling the "black box" of pregnancy with a new imaging technique called pseudo-continuous arterial spin labeling magnetic resonance imaging (pCASL MRI), which tracks maternal blood flow to the placenta.
Nov 26, 2019
-
Diagnostics World News | Some of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.
Nov 22, 2019
-
Diagnostics World | Kenna Mills-Shaw believes that precision oncology is neither an illusion nor a panacea. But while there have been some dramatic wins for specific, molecularly-defined tumors, scaling precision oncology will require a highly integrated decision support platform.
Nov 19, 2019
-
Diagnostics World News | An early-stage startup is endeavoring to help clinical teams deliver high-value critical care with precision, and its first target is sepsis.
Nov 18, 2019
-
Diagnostics World News | A machine learning algorithm that contains the novel biomarker neutrophil gelatinase-associated lipocalin looks like a big win for patients with severe burns. It can help predict acute kidney injury close to two days before clinical symptoms are detectable by conventional diagnostic measures alone.
Nov 15, 2019